These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35342452)

  • 1. A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive-compulsive disorder.
    Ebrahimi A; Nasre Esfahan E; Akuchekian S; Izadi R; Shaneh E; Mahaki B
    J Res Med Sci; 2022; 27():9. PubMed ID: 35342452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptance and Commitment Therapy, Selective Serotonin Reuptake Inhibitors and Their Combination in the Improvement of Obsessive-Compulsive Symptoms and Experiential Avoidance in Patients With Obsessive-Compulsive Disorder.
    Vakili Y; Gharaee B; Habibi M
    Iran J Psychiatry Behav Sci; 2015 Jun; 9(2):e845. PubMed ID: 26288647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran.
    Zemestani M; Salavati M; Seyedolshohadayi A; Petersen JM; Ong CW; Twohig MP; Ghaderi E
    Behav Modif; 2022 May; 46(3):553-580. PubMed ID: 33356487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoping Review of Acceptance and Commitment Therapy for Obsessive-Compulsive Disorder in Iran.
    Twohig MP; Seydavi M; Capel LK; Levin ME; Akbari M
    J Cogn Psychother; 2024 Jul; 38(3):211-226. PubMed ID: 38991742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder.
    Twohig MP; Hayes SC; Plumb JC; Pruitt LD; Collins AB; Hazlett-Stevens H; Woidneck MR
    J Consult Clin Psychol; 2010 Oct; 78(5):705-16. PubMed ID: 20873905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptance and commitment therapy as an add-on treatment for the management of patients with obsessive-compulsive disorder.
    Akhouri D; Hamza ; Kumar S; Reyazuddin M
    Ind Psychiatry J; 2023 Nov; 32(Suppl 1):S179-S185. PubMed ID: 38370965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder.
    Shahini N; Talaei A; Shalbafan M; Faridhosseini F; Ziaee M
    Basic Clin Neurosci; 2021; 12(4):489-498. PubMed ID: 35154589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive-Behavioral Therapy Versus Transcranial Direct Current Stimulation for Augmenting Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder Patients.
    Dadashi M; Yousefi Asl V; Morsali Y
    Basic Clin Neurosci; 2020; 11(1):111-120. PubMed ID: 32483481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sertraline and fluvoxamine on quality of life in patients with obsessive-compulsive disorder: A 12-week interventional study.
    Brar J; Sidana A; Chauhan N; Bajaj MK
    Ind Psychiatry J; 2022; 31(1):26-30. PubMed ID: 35800875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effectiveness of acceptance and commitment therapy (ACT) with metacognitive therapy (MCT) in objective cognitive information processing style of obsessive-compulsive patients (OCD).
    Saeidi L; Afsharinia K; Kakabraee K; Arefi M
    J Educ Health Promot; 2023; 12():371. PubMed ID: 38144015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
    Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
    Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Applicability of Acceptance and Commitment Therapy for Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.
    Soondrum T; Wang X; Gao F; Liu Q; Fan J; Zhu X
    Brain Sci; 2022 May; 12(5):. PubMed ID: 35625042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in obsessive-compulsive disorder: the different impact of obsessions and compulsions.
    Stengler-Wenzke K; Kroll M; Riedel-Heller S; Matschinger H; Angermeyer MC
    Psychopathology; 2007; 40(5):282-9. PubMed ID: 17622707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial impact of obsessive-compulsive disorder on patients and their caregivers: a comparative study with depressive disorder.
    Vikas A; Avasthi A; Sharan P
    Int J Soc Psychiatry; 2011 Jan; 57(1):45-56. PubMed ID: 21252355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with obsessive compulsive disorder: A longitudinal study from India.
    Srivastava S; Bhatia MS; Thawani R; Jhanjee A
    Asian J Psychiatr; 2011 Sep; 4(3):178-82. PubMed ID: 23051114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of cognitive behavioral therapy and fluoxetine on sexual function of women with obsessive compulsive disorder: A double-blind randomized controlled trial.
    Sabetnejad Z; Assarian F; Omidi A; Najarzadegan MR
    Electron Physician; 2016 Nov; 8(11):3156-3163. PubMed ID: 28070247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: A randomized double-blind placebo-controlled trial.
    Jahanbakhsh SP; Manteghi AA; Emami SA; Mahyari S; Gholampour B; Mohammadpour AH; Sahebkar A
    Complement Ther Med; 2016 Aug; 27():25-9. PubMed ID: 27515872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of cognitive function in treatment-refractory obsessive-compulsive disorder treated with capsulotomy.
    Gong F; Li P; Li B; Zhang S; Zhang X; Yang S; Liu H; Wang W
    J Neurosurg; 2018 Feb; 128(2):583-595. PubMed ID: 28338440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding acceptance and commitment therapy to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial.
    Twohig MP; Abramowitz JS; Smith BM; Fabricant LE; Jacoby RJ; Morrison KL; Bluett EJ; Reuman L; Blakey SM; Ledermann T
    Behav Res Ther; 2018 Sep; 108():1-9. PubMed ID: 29966992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.
    Ma ZR; Shi LJ
    Int J Clin Exp Med; 2014; 7(12):4897-905. PubMed ID: 25663986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.